SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-13-187228
Filing Date
2013-04-30
Accepted
2013-04-30 16:11:58
Documents
5
Effectiveness Date
2013-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d525749ddefa14a.htm DEFA14A 27429
2 GRAPHIC g525749na1v2.jpg GRAPHIC 137858
3 GRAPHIC g525749na2v2.jpg GRAPHIC 198552
4 GRAPHIC g525749na3v2.jpg GRAPHIC 78548
5 GRAPHIC g525749na4v2.jpg GRAPHIC 56389
  Complete submission text file 0001193125-13-187228.txt   678640
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-24006 | Film No.: 13797594
SIC: 2834 Pharmaceutical Preparations